Mitochondrial Switches for Stem Cell Self-Renewal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reversing biological aging focus on extending telomeres or removing senescent cells, but these approaches either allow cells to continue aging epigenetically or have limited effectiveness in reversing epigenetic age.
Innovation Solution
The use of mitochondrial switches to promote stem cell self-renewal, combined with demethylase and biogenesis promoters, to expand stem cell pools and reduce epigenetic age by modifying mitochondrial morphology and ATP production, along with nutritional supplementation to support stem cell function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If telomeres are extended with supplements such as astragalus extracts containing cycloastragenol, then the Hayflick crisis is delayed and short-term health benefits are provided, but cells continue to age epigenetically and become ever more dysfunctional
Solution Approach 1:
Instead of extending telomeres to delay senescence, the patent inverts the approach by using senolytic compounds to eliminate senescent cells and by activating telomerase to extend telomeres in a controlled manner, thereby preventing senescence rather than dealing with its consequences. This resolves the contradiction by addressing the root cause of cellular dysfunction.
Solution Approach 2:
The patent changes the parameters of telomere maintenance by introducing telomerase activation through specific compounds, which alters the rate of telomere shortening and delays the Hayflick limit. Simultaneously, senolytic compounds change the parameter of senescent cell population, reducing their accumulation and maintaining cellular function.
2Productivity
If senescent cells are removed naturally by apoptosis, then cellular turnover is maintained, but with age the number of cells reaching senescence increases while stem cell pools decline and clearance processes fail to keep up
Solution Approach 1:
The patent extracts senescent cells from the system using senolytic compounds that induce selective apoptosis in senescent cells while sparing healthy cells. This active removal process complements natural apoptosis and prevents the accumulation of senescent cells that would otherwise deplete stem cell pools through competitive inhibition and inflammatory effects.
Solution Approach 2:
The patent applies preliminary action by using senolytic compounds to preemptively eliminate senescent cells before they can accumulate and exert harmful effects on stem cell pools. This prevents the vicious cycle of senescence accumulation and stem cell depletion from establishing itself.
3Use of energy by moving object
If mitochondrial DNA becomes hypermethylated and dysfunctional, then ATP production is reduced and aging occurs, but methods for reducing mtDNA methylation are needed to increase ATP and athletic performance
Solution Approach 1:
The patent converts the harmful effect of mtDNA methylation into a beneficial outcome by using demethylating agents that specifically target methylated mtDNA. These agents reverse the methylation process, restoring mitochondrial function and ATP production. The same compounds that cause concern for genomic stability actually benefit mitochondrial health by removing inhibitory methylation marks.
Data Source
AI summary
Disclosed are methods and compositions for reducing the epigenetic age of organisms, especially that of adult humans, which provide for proliferating endogenous stem cells, removing aberrant epigenetic marks from chromosomes and mitochondrial DNA, and replacement of senescent cells.